Cited by 363Hormonal and reproductive studiesAdrenal Hormones and DisordersMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 251 of the 257 references it cites were found in a registry or an index.

Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline

Open access

Wierman, Margaret E., Arlt, Wiebke, Basson, Rosemary, Davis, Susan R., Miller, Karen K., Murad, Mohammad H., Rosner, William, Santoro, Nanette·2014·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2014-2260

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To update practice guidelines for the therapeutic use of androgens in women. PARTICIPANTS: A Task Force appointed by the Endocrine Society, American Congress of Obestricians and Gynecologists (ACOG), American Society for Reproductive Medicine (ASRM), European Society of Endocrinology (ESE), and International Menopause Society (IMS) consisting of six experts, a methodologist, and a medical writer. EVIDENCE: The Task Force commissioned two systematic reviews of published data and considered several other existing meta-analyses and trials. The GRADE methodology was used; the strength of a recommendation is indicated by a number "1" (strong recommendation, we recommend) or "2" (weak recommendation, we suggest). CONSENSUS PROCESS: Multiple e-mail communications and conference calls determined consensus. Committees of the Endocrine Society, ASRM, ACOG, ESE, and IMS reviewed and commented on the drafts of the guidelines. CONCLUSIONS: We continue to recommend against making a diagnosis of androgen deficiency syndrome in healthy women because there is a lack of a well-defined syndrome, and data correlating androgen levels with specific signs or symptoms are unavailable. We recommend against the general use of T for the following indications: infertility; sexual dysfunction other than hypoactive sexual desire disorder; cognitive, cardiovascular, metabolic, or bone health; or general well-being. We recommend against the routine use of dehydroepiandrosterone due to limited data concerning its effectiveness and safety in normal women or those with adrenal insufficiency. We recommend against the routine prescription of T or dehydroepiandrosterone for the treatment of women with low androgen levels due to hypopituitarism, adrenal insufficiency, surgical menopause, pharmacological glucocorticoid administration, or other conditions associated with low androgen levels because there are limited data supporting improvement in signs and symptoms with therapy and no long-term studies of risk. Evidence supports the short-term efficacy and safety of high physiological doses of T treatment of postmenopausal women with sexual dysfunction due to hypoactive sexual desire disorder. Importantly, endogenous T levels did not predict response to therapy. At present, physiological T preparations for use in women are not available in many countries including the United States, and long-term safety data are lacking. We recommend that any woman receiving T therapy be monitored for signs and symptoms of androgen excess. We outline areas for future research. Ongoing improvement in androgen assays will allow a redefinition of normal ranges across the lifespan; this may help to clarify the impact of varying concentrations of plasma androgens on the biology, physiology, and psychology in women and lead to indications for therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2014-2260

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.606 · Cited by 1,799
Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group
Atkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
Sex‐hormone binding-globulin
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature
Södergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080

Show all 257 references

Research works printed but not linked: 6

[13]13. Braunstein GD, Reitz RE, Buch A, Schnell D, Caulfield MP. Tes- tosterone reference ranges in normally cycling healthy premeno- pausal women. J Sex Med. 2011;8:2924 -2934.
[28]28. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free tes- tosterone formulae in men. Clin Endocrinol (Oxf). 2010;73:382- 388.
[31]31. Rosner W. An extraordinarily inaccurate assay for free testoster- one is still with us. J Clin Endocrinol Metab. 2001;86:2903.
[179]179. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hyster- ectomy and sexual functioning. JAMA. 1999;282:1934 -1941.
[182]182. Snabes MC, Zborowski J, Simes S. Libigel (testosterone gel) does not differentiate from placebo therapy in the treatment of hypo- active sexual desire in postmenopausal women. J Sex Med. 2012; 3:171.
[195]195. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer. 1997;79:494 -499.

Sorted by citations

Items 101–200 of 357

Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism
Olivius, C., Landin‐Wilhelmsen, K., Olsson, D. S., Johannsson, G., & Tivesten, Å. (2018) · Pituitary · doi:10.1007/s11102-018-0895-1 · Cited by 18
The Saga of Testosterone for Menopausal Women at the Food and Drug Administration (FDA)
Simon, J. A., & Kapner, M. D. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.01.009 · Cited by 18
The sexuological impact of hormonal contraceptives based on their route of administration
Guida, M., Carlo, C. D., Troisi, J., Gallo, A., Cibarelli, F., Martini, E., Tiranini, L., & Nappi, R. E. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1249841 · Cited by 18
The role of androgens on periodontal repair in female rats
Steffens, J. P., Santana, L. C. L., Pitombo, J. C. P., Ribeiro, D. O., Albaricci, M. C. D. C., Warnavin, S. V. S. C., Kantarcı, A., & Spolidório, L. C. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0435 · Cited by 18
Premature ovarian insufficiency: a toolkit for the primary care physician
Lambrinoudaki, I. V., Paschou, S. Α., Lumsden, M. A., Faubion, S. S., Makrakis, E., Kalantaridou, S., & Panay, N. (2021) · Climacteric · doi:10.1080/13697137.2020.1859246 · Cited by 18
Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options
Pesantez, G. S. P., & Clayton, A. H. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200039 · Cited by 18
Fertility in childhood cancer survivors following cranial irradiation for primary central nervous system and skull base tumors
Vern-Gross, T. Z., Bradley, J. A., Rotondo, R. L., & Indelicato, D. J. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.10.001 · Cited by 18
The effects of dehydroepiandrosterone (DHEA) supplementation on body composition and blood pressure: A meta-analysis of randomized clinical trials
Wang, F., He, Y., Santos, H. O., Sathian, B., Price, J. C., & Diao, J. (2020) · Steroids · doi:10.1016/j.steroids.2020.108710 · Cited by 17
Vaginal Testosterone for Management of Aromatase Inhibitor–Related Sexual Dysfunction: An Integrative Review
Lemke, E., Madsen, L. T., & Dains, J. E. (2017) · Oncology nursing forum · doi:10.1188/17.onf.296-301 · Cited by 17
Financial Conflicts of Interest Among Authors of Endocrine Society Clinical Practice Guidelines*
Irwig, M. S., Kyinn, M., & Shefa, M. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00526 · Cited by 17
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · Climacteric · doi:10.1080/13697137.2021.1891773 · Cited by 19
Self-citation
Androgen Receptor Polymorphism and Female Sexual Function and Desire
Wåhlin-Jacobsen, S., Flanagan, J. N., Pedersen, A. T., Kristensen, E., Arver, S., & Giraldi, A. G. E. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.09.013 · Cited by 16
Premature ovarian insufficiency: A hormonal treatment approach
Benetti‐Pinto, C. L., Soares, J. M., Maciel, G. A. R., Nácul, A. P., Yela, D. A., & Silva, A. C. J. D. S. R. E. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1716929 · Cited by 18
A Review on Testosterone: Estradiol Ratio—Does It Matter, How Do You Measure It, and Can You Optimize It?
Swislocki, A., & Eisenberg, M. L. (2024) · The World Journal of Men s Health · doi:10.5534/wjmh.240029 · Cited by 17
Detection of testosterone microdosing in healthy females
Savkovic, S., Ly, L. P., Desai, R., Howa, J. D., Nair, V. S., Eichner, D., & Handelsman, D. J. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3202 · Cited by 15
The prevalence of sexual dysfunction among postpartum women on the East Coast of Malaysia
Khalid, N., Jamani, N. A., Aziz, K. H. A., & Draman, N. (2020) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2020.08.008 · Cited by 14
Sex differences in the serum level of endogenous ligands for estrogen receptor β in the elderly population
Kobayashi, M., Sugiyama, N., Sasayama, D., Sasamoto, H., Miyashiro, Y., Arima, K., & Washizuka, S. (2016) · Scientific Reports · doi:10.1038/srep25878 · Cited by 14
Central adrenal insufficiency: who, when, and how? From the evidence to the controversies – an exploratory review
Bitencourt, M. R., Batista, R. L., Biscotto, I. P., & Carvalho, L. R. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000493 · Cited by 15
Hormonal profile of menopausal women receiving androgen replacement therapy: a meta-analysis
Marina, L., Šojat, A. S., Maseroli, E., Spaggiari, G., Pandurevic, S., & Santi, D. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01192-x · Cited by 32
Breast and cervical cancer in transgender men: literature review and a case report
Lisa, F. S. D., Villa, A., Filomeno, L., Arcuri, T., Chiofalo, B., Sanguineti, G., Pizzuti, L., Krasniqi, E., Barba, M., Sergi, D., et al. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241259466 · Cited by 13
Androgens in premenopausal women and women with premature ovarian insufficiency
Davis, S. R. (2021) · Climacteric · doi:10.1080/13697137.2020.1866530 · Cited by 12
Self-citation
The 2025 Menopausal Hormone Therapy Guidelines - Korean Society of Menopause
Kim, Y. J., Cho, M. K., Chung, Y., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., Lee, D., et al. (2025) · Journal of Menopausal Medicine · doi:10.6118/jmm.25103 · Cited by 17
The testosterone prescribing practice of BMS menopause specialists
Scott, A., Holloway, D., RYMER, J. M., & Bruce, D. (2021) · Post Reproductive Health · doi:10.1177/2053369120985743 · Cited by 30
Approach to the Patient: A Case With an Unusual Cause of Hypopituitarism
Das, L., & Dutta, P. R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac747 · Cited by 12
Sex Hormones and Cardiovascular Disease in Relation to Menopause
Kim, C., & Wellons, M. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.005 · Cited by 13
Psychological, Social, and Spiritual Effects of Contraceptive Steroid Hormones
Klaus, H., & Cortés, M. E. (2015) · The Linacre Quarterly · doi:10.1179/2050854915y.0000000009 · Cited by 12
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 15
Self-citation
A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes
Rochester-Eyeguokan, C. D., & Meade, L. T. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0313-0 · Cited by 12
Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece
Bompoula, M. S., Valsamakis, G., Neofytou, S., Messaropoulos, P., Salakos, N., Mastorakos, G. P., & Kalantaridou, S. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1739266 · Cited by 12
Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians
Cocchetti, C., Ristori, J., Mazzoli, F., Vignozzi, L., Maggi, M., & Fisher, A. D. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00409-8 · Cited by 13
Pathophysiology and Medical Management of Hypoactive Sexual Desire Disorder
Clayton, A. H., & Vignozzi, L. (2018) · Wiley eBooks · doi:10.1002/9781119266136.ch6 · Cited by 13
Guideline No. 422d: Menopause and Sexuality
Wolfman, W., Krakowsky, Y., & Fortier, M. P. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.09.005 · Cited by 13
New Possibilities for Hormonal Vaginal Treatment in Menopausal Women
Tomczyk, K., Chmaj-Wierzchowska, K., Wszołek, K., & Wilczak, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144740 · Cited by 11
Sex Steroid Replacement Therapy in Female Hypogonadism from Childhood to Young Adulthood
Norjavaara, E., Ankarberg‐Lindgren, C., & Kriström, B. (2015) · Endocrine development · doi:10.1159/000438892 · Cited by 11
First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women
Robinson, K., Cutler, J. B. R., & Carris, N. W. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015622182 · Cited by 11
Long-term follow-up of a female patient with non-classical 11 β -hydroxylase deficiency and two novel mutations in CYP11B1
Zacharieva, S., Robeva, R. N., Andonova, S., Vazharova, R., Balabanski, L., Atanasoska, M., Toncheva, D. I., Elenkova, A. P., & Savov, A. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1482870 · Cited by 11
Depressive symptoms are not associated with long-term integrated testosterone concentrations in hair
Walther, A., Wehrli, S., Kische, H., Penz, M., Wekenborg, M., Gao, W., Rothe, N., Beesdo-Baum, K., & Kirschbaum, C. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1795253 · Cited by 8
Testosterone for midlife women
Shifren, J. L. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000540 · Cited by 11
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
L'Hermite, M. (2017) · Climacteric · doi:10.1080/13697137.2017.1285277 · Cited by 11
Effect of Zinc on Testosterone Levels and Sexual Function of Postmenopausal Women: A Randomized Controlled Trial
Nia, L. M., Iravani, M., Abedi, P., & Cheraghian, B. (2021) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2021.1957732 · Cited by 10
Androgen deficiency in hypopituitary women: its consequences and management
Esposito, D., Tivesten, Å., Olivius, C., Ragnarsson, O., & Johannsson, G. (2024) · Reviews in Endocrine & Metabolic Disorders · doi:10.1007/s11154-024-09873-1 · Cited by 8
DHEA on Sexual Function in Sheehan Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial
Mandal, S., Mukhopadhyay, P., & Ghosh, S. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac260 · Cited by 9
Sexual dysfunction in women: Can we talk about it?
Faubion, S. S., & Parish, S. J. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.16021 · Cited by 11
Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
Johansen, N., Liavaag, A. H., Mørkrid, L., & Michelsen, T. M. (2018) · Sexual Medicine · doi:10.1016/j.esxm.2018.02.002 · Cited by 9
Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy
Björk, Y., Knutsson, E. S., Ankarberg‐Lindgren, C., Broman, A.-K., Andersson, I., Björkman, L. I., Magnusson, J. M., Bergmark, K. H., Anderson, H., Andersson, P.-O., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.268 · Cited by 9
Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
Santos, B. M., de Souza, J. P. A., Goulart, L. R. D. P., Petrine, J. C. P., Alves, F. H. F., & Borges, B. D. B. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102205 · Cited by 9
Risks of Testosterone for Postmenopausal Women
Pinkerton, J. V., Blackman, I., Conner, E. A., & Kaunitz, A. M. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.007 · Cited by 27
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial
Wang, A., Gerstein, H. C., Lee, S. F., Hess, S., Paré, G., Rydén, L., & Mellbin, L. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211002475 · Cited by 8
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency
Bennett, G., Cussen, L., & O’Reilly, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000728 · Cited by 8
Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause
Rech, C. M. Z., Clapauch, R., & Bouskela, E. (2019) · Journal of Women s Health · doi:10.1089/jwh.2017.6905 · Cited by 8
Production of fertile YY pseudofemales in Nile tilapia with LG23 as the sex chromosome
Liu, X., Li, Z., Li, W., Zhang, L. N., Li, M., & Wang, D. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.740870 · Cited by 7
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality
Donald, D. M., McDonnell, T., O’Reilly, M., & Sherlock, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09897-7 · Cited by 7
Hyperandrogenic Anovulation
Wierman, M. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.12.003 · Cited by 7
Self-citation
Testosterone Implant Therapy in Women With and Without Breast Cancer: Rationale, Experience, Evidence
Glaser, R. L., & Dimitrakakis, C. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0003 · Cited by 9
Androgen therapy for women after menopause
Marko, K. I., & Simon, J. A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101592 · Cited by 11
Hormonal assessment of participants in a long distance walk
de Souza, H. S., Jardim, T. V., Barroso, W. K. S., Vitorino, P. V. D. O., Souza, A. L. L., & Jardim, P. C. B. V. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0414-1 · Cited by 7
An evaluation of the prevalence and predictive factors of sexual dysfunction in women with heart failure: A cross‐sectional survey
Küçükkaya, H., & Gönenç, İ. M. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16578 · Cited by 7
Testosterone in women: can the challenges be met?
Davis, S. R., & Parish, S. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00207-7 · Cited by 7
Self-citation
Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Knee Arthroplasty: A Propensity-Matched Analysis of 13,250 Patients
Omurzakov, A., Omurzakov, A. M., Bhatti, P., Debbi, E. M., Gausden, E. B., & Chalmers, B. P. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.10.066 · Cited by 7
Premature Ovarian Insufficiency, Menopause, and Hormone Replacement Therapy
Conway, G. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_41 · Cited by 6
Sexual Health Matters: Management of Female Sexual Dysfunction
Vegunta, S., Kling, J. M., & Faubion, S. S. (2016) · Journal of Women s Health · doi:10.1089/jwh.2016.5991 · Cited by 6
Higher testosterone is associated with open-angle glaucoma in women: a genetic predisposition?
Vergroesen, J. E., Kaynak, A., Aribas, E., Kavousi, M., van Meurs, J. B. J., Klaver, C. C. W., & Ramdas, W. D. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00512-z · Cited by 8
What does the research say about androgen use and cerebrovascular events?
Sadaie, M. R., Farhoudi, M., Zamanlu, M., Aghamohammadzadeh, N., Amouzegar, A., Rosenbaum, R. E., & Thomas, G. A. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618773318 · Cited by 7
Concerns about safety and efficacy of compounded bioidentical hormone therapy
Pinkerton, J. V. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001813 · Cited by 6
Evaluation and management of hypoactive sexual desire disorder in women. Recommendations from the 5th International Consultation on Sexual Medicine (ICSM 2024)
Rowen, T. S., Abdo, C. H. N., Kak, F. E., Maseroli, E., Pope, R., Prasad, P., Velten, J., & Vignozzi, L. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf057 · Cited by 5
Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women
Zeng, J., Xie, T.-F., Huang, T., Li, F., Wang, Z., & Feng, L. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-021-02201-9 · Cited by 5
Concerns About Compounded Bioidentical Menopausal Hormone Therapy
Pinkerton, J. V. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000597 · Cited by 5
Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder—a claims database analysis
Agrawal, P. M., Lee, Y. S., Grutman, A. J., Dumas, K., Kohn, T. P., Kohn, J. R., Yee, A. M., & Clifton, M. M. (2024) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdae013 · Cited by 5
When Lowest Dose for Shortest Amount of Time Does Not Apply
Faubion, S. S., Files, J. A., & Rocca, W. A. (2016) · Journal of Women s Health · doi:10.1089/jwh.2016.5781 · Cited by 5
Testosterone in Females
Cipriani, S., Maseroli, E., & Vignozzi, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_8 · Cited by 5
Current use of testosterone therapy in LGBTQ populations
Tijerina, A. N., Srivastava, A. V., Patel, V. R., & Osterberg, E. C. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00490-z · Cited by 4
Cognitive dysfunction in patients with primary adrenal insufficiency: A systematic review
Ramos-Levi, A. M., Cañada, E., & Matías‐Guiu, J. A. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2090256 · Cited by 5
Hormones and Sex Behavior
Vignozzi, L., & Maseroli, E. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_6 · Cited by 5
Bioidentical hormone therapy
Richardson, M. K. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000629 · Cited by 5
Testosterone therapy for female sexual dysfunction: a systematic review of the literature demonstrating outcomes in premenopausal and postmenopausal women
Furlan, V. A., Hammad, M. A. M., Quesada, S. G., Nguyen, S., & Yih, J. (2026) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdag206 · Cited by 4
Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study
Stergianos, S., Spelman, T. D., Eriksson, D., Öster, S., Björnsdóttir, S., Kämpe, O., Skov, J., & Bensing, S. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20085 · Cited by 4
Comparison of topical estrogen and platelet-rich plasma injections in the treatment of postmenopausal vaginal atrophy
Atlıhan, U., Ata, C., Yavuz, O., Avşar, H. A., Erkılınç, S., & Bıldacı, T. B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1590078 · Cited by 4
Topical androgen therapy: a potential advancement in treating post-menopausal dry eye
Pandey, H., Kumar, R., & Kagithala, N. R. (2025) · Clinical and Experimental Optometry · doi:10.1080/08164622.2025.2509586 · Cited by 4
Clinical management of androgen excess and defect in women
Rosato, E., Sciarra, F., Minnetti, M., Degjoni, A., & Venneri, M. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279537 · Cited by 4
Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction
Lowenstein, L., Shechter, A., Porst, H., Tripodi, F. M., & Reisman, Y. (2016) · International Journal of Impotence Research · doi:10.1038/ijir.2016.2 · Cited by 4
Sexual Health and Function in Menopause and Beyond
Verrilli, L. E., Esposito-Smith, M., & Williams, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-59058-1_12 · Cited by 5
Do Women Need Androgens Like a Fish Needs a Bicycle? A Review of the Literature and Clinical Guidelines
Santoro, N., & Wierman, M. E. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000658 · Cited by 4
Self-citation
Use of androgens at different stages of life: reproductive period
Nácul, A. P., Rezende, G. P., Yela, D. A., Maranhão, T. M. D. O., Costa, L. O. B. F., dos Reis, F. M., Maciel, G. A. R., Damásio, L. C. V. D. C., Silva, A. C. J. D. S. R. E., Lopes, V. M., et al. (2021) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1740610 · Cited by 4
Androgene und weibliche Libido
Sartorius, G. A. (2017) · Gynäkologische Endokrinologie · doi:10.1007/s10304-017-0137-z · Cited by 4
Pharmacological Advances in the Management of Sexual Dysfunction
Reddy, M. S. S., & Vijay, M. S. (2017) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.207318 · Cited by 4
Testosterone Therapy in Women: A Clinical Challenge.
Dunsmoor-Su, R. F., Fuller, A., & Voedisch, A. J. (2021) · PubMed · doi:10.1097/aog.0000000000004566 · Cited by 3
The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
Huang, X., Wu, L., Zhang, Y., Lai, X., & Sun, D. (2025) · Endocrine Connections · doi:10.1530/ec-25-0162 · Cited by 3
Recovering sex drive in women — progress and opportunities
Nappi, R. E., & Albani, F. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2015.314 · Cited by 3
Testosterone and Women
Clapauch, R., Weiss, R. V., & Rech, C. M. Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_17 · Cited by 4
Androgen deficiency in women with adrenal insufficiency. Dehydroepiandrosterone. Review
Nuralieva, N., Yukina, M., Troshina, E., & Platonova, N. (2018) · Gynecology · doi:10.26442/2079-5696_2018.4.35-39 · Cited by 1
Examining the Role of Physical Activity Interventions in Modulating Androgens and Cardiovascular Health in Postmenopausal Women: A Narrative Review
Elliott, C. G., Vidal‐Almela, S., Harvey, P., O’Donnell, E., Scheid, J. L., Visintini, S. M., & Reed, J. L. (2022) · CJC Open · doi:10.1016/j.cjco.2022.10.008 · Cited by 3
Primary Ovarian Insufficiency and Hormone Replacement Therapy: A Review Article
Pratiwi, E. (2023) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20230132 · Cited by 3
Research on liposomal hydrogels loaded with "Liu Zi Tang" compound Chinese medicine for the treatment of primary ovarian insufficiency
Liu, C., Zhang, Y. C., Xiao, H., Tan, G., Cao, C., Lao, Y., & Huang, Y. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100337 · Cited by 3
Challenges of prescribing testosterone for sexual dysfunction in women: Number 7 – 2024
Lara, L. A. D. S., Pereira, J. M. D. L., de Paula, S. R. C., de Oliveira, F. F. L., Cunha, A. M., Lerner, T., de Carvalho, Y. M. V., Rezende, G. P., & Benetti‐Pinto, C. L. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024fps07 · Cited by 3
Alternatives of menopausal hormone therapy
Kutlesic, R. M., Popović, J., Stefanović, M., Vukomanović, P., Lukic, B., & Lilić, G. (2016) · Medicinski pregled · doi:10.2298/mpns1606177k · Cited by 3
Climacteric Symptoms: Importance and Management
Birkhaeuser, M. H. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_4 · Cited by 5
Best practices in care for menopausal patients: 16 years after the Women's Health Initiative
DeNeui, T., Berg, J. A., & Howson, A. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000186 · Cited by 3
Testosterone Prescribing Among Women in the USA, 2002–2017
Baillargeon, J., Urban, R. J., Raji, M. A., Westra, J. R., Williams, S. B., López, D. S., & Kuo, Y. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05365-0 · Cited by 3
Use of androgens at different stages of life: climacterium
Nácul, A. P., Rezende, G. P., Yela, D. A., Maranhão, T. M. D. O., Costa, L. O. B. F., dos Reis, F. M., Maciel, G. A. R., Damásio, L. C. V. D. C., Silva, A. C. J. D. S. R. E., Lopes, V. M., et al. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1740936 · Cited by 4
Update on canine anorchia: A review
Cicirelli, V., Burgio, M., Mrenoshki, D., Cseh, S., Aiudi, G. G., & Lacalandra, G. M. (2023) · Veterinary Medicine and Science · doi:10.1002/vms3.1033 · Cited by 3

Authors: Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N.
Affiliations: University of British Columbia (CA)
University of Birmingham (GB)
Veterans Health Administration (US)
Massachusetts General Hospital (US)
Mayo Clinic (US)
ORCID: Wierman, Margaret E.
Arlt, Wiebke
Basson, Rosemary
Davis, Susan R.
Miller, Karen K.
Murad, Mohammad H.
Santoro, Nanette
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2014-10
Volume: 99
Issue: 10
Pages: 3489-3510
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2014-2260
OpenAlex: W2169638329
Semantic Scholar: 0ab9fec7488d4092d18727dbe6ea5d548da84c6e
Cited by: 363
References: 257
Citations by year: 2026: 18 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 52 · 2021: 46 · 2020: 28 · 2019: 25 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 25 · 2014: 3
FWCI: 23.88
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: androgen therapy, women, testosterone, dehydroepiandrosterone, hypoactive sexual desire disorder, postmenopausal women, adrenal insufficiency, hypopituitarism, surgical menopause, hyperandrogenism, infertility, sexual dysfunction, bone health, cardiovascular risk, treatment safety
MeSH terms: Contraindications, Androgens, Endocrinology, Female, Humans, Hypopituitarism, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks